Revenue - Vaxart Inc (NASDAQ:VXRT) - Alpha Spread

Vaxart Inc
NASDAQ:VXRT

Watchlist Manager
Vaxart Inc Logo
Vaxart Inc
NASDAQ:VXRT
Watchlist
Price: 0.8344 USD -7.91% Market Closed
Market Cap: 189.8m USD
Have any thoughts about
Vaxart Inc?
Write Note

Vaxart Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vaxart Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Vaxart Inc
NASDAQ:VXRT
Revenue
$13.9m
CAGR 3-Years
123%
CAGR 5-Years
13%
CAGR 10-Years
-15%
Abbvie Inc
NYSE:ABBV
Revenue
$55B
CAGR 3-Years
1%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.8B
CAGR 3-Years
1%
CAGR 5-Years
4%
CAGR 10-Years
5%
Amgen Inc
NASDAQ:AMGN
Revenue
$30.9B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$10.3B
CAGR 3-Years
16%
CAGR 5-Years
25%
CAGR 10-Years
29%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.5B
CAGR 3-Years
3%
CAGR 5-Years
16%
CAGR 10-Years
18%

Vaxart Inc
Revenue Breakdown

Breakdown by Geography
Vaxart Inc

Not Available

Breakdown by Segments
Vaxart Inc

Total Revenue: 7.4m USD
100%
Non Cash Royalty Revenue: 3.9m USD
53.1%
Grant: 3.5m USD
46.9%

See Also

What is Vaxart Inc's Revenue?
Revenue
13.9m USD

Based on the financial report for Jun 30, 2024, Vaxart Inc's Revenue amounts to 13.9m USD.

What is Vaxart Inc's Revenue growth rate?
Revenue CAGR 10Y
-15%

Over the last year, the Revenue growth was 576%. The average annual Revenue growth rates for Vaxart Inc have been 123% over the past three years , 13% over the past five years , and -15% over the past ten years .

Back to Top